Table 1.
Clinic pathological variables of the patients included in this study.
| Item | No./Total No. | % |
|---|---|---|
| Age, years | ||
| <49 | 139/250 | 55.6 |
| >49 | 111/250 | 44.4 |
| Number of Positive Nodes | ||
| 0 | 151/250 | 60.4 |
| ≥1 | 97/250 | 38.8 |
| Not available (NA’s) | 2/250 | 0.8 |
| Tumor Size, pT | ||
| pT1 | 110250 | 44 |
| pT2/3/4 | 137/250 | 54.8 |
| Not available (NA’s) | 3/250 | 1.2 |
| FIGO | ||
| I | 64/250 | 25.6 |
| II/III/IV | 92/250 | 36.8 |
| Not available (NA’s) | 94/250 | 37.6 |
| Tumor Grade | ||
| I | 21/250 | 8.4 |
| II | 143/250 | 57.2 |
| III | 78/250 | 31.2 |
| Not available (NA’s) | 8/250 | 3.2 |
| Tumor Subtype | ||
| Squamous | 202/250 | 80.8 |
| Adenocarcinoma | 48/250 | 19.2 |
| Progression (over 235 months) | ||
| None | 210/250 | 84 |
| At least one | 21/250 | 11.6 |
| Not available (NA’s) | 11/250 | 4.4 |
| Survival (over 235 months) | ||
| Right censured | 190/250 | 76 |
| Died | 49/250 | 19.6 |
| Not available (NA’s) | 11/250 | 4.4 |